Trexquant Investment LP Invests $6.17 Million in Chemed Co. (NYSE:CHE)

Trexquant Investment LP bought a new stake in Chemed Co. (NYSE:CHE) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 11,650 shares of the company’s stock, valued at approximately $6,172,000. Trexquant Investment LP owned approximately 0.08% of Chemed at the end of the most recent reporting period.

Several other hedge funds have also bought and sold shares of CHE. CIBC Asset Management Inc raised its position in shares of Chemed by 5.1% during the 4th quarter. CIBC Asset Management Inc now owns 457 shares of the company’s stock valued at $242,000 after buying an additional 22 shares in the last quarter. CBIZ Investment Advisory Services LLC increased its stake in Chemed by 64.7% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 56 shares of the company’s stock valued at $30,000 after acquiring an additional 22 shares during the last quarter. CIBC Private Wealth Group LLC raised its position in Chemed by 13.5% during the fourth quarter. CIBC Private Wealth Group LLC now owns 185 shares of the company’s stock valued at $98,000 after purchasing an additional 22 shares in the last quarter. EP Wealth Advisors LLC lifted its stake in Chemed by 1.9% during the third quarter. EP Wealth Advisors LLC now owns 1,354 shares of the company’s stock worth $814,000 after purchasing an additional 25 shares during the last quarter. Finally, Independent Advisor Alliance boosted its holdings in shares of Chemed by 1.1% in the 4th quarter. Independent Advisor Alliance now owns 2,279 shares of the company’s stock worth $1,207,000 after purchasing an additional 25 shares in the last quarter. 95.85% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on CHE shares. StockNews.com upgraded Chemed from a “hold” rating to a “buy” rating in a research report on Friday, March 7th. Royal Bank of Canada boosted their price objective on shares of Chemed from $633.00 to $667.00 and gave the stock an “outperform” rating in a report on Friday, March 14th.

Insider Activity

In other news, CEO Kevin J. Mcnamara sold 1,000 shares of the business’s stock in a transaction that occurred on Monday, March 31st. The stock was sold at an average price of $615.33, for a total transaction of $615,330.00. Following the transaction, the chief executive officer now directly owns 101,679 shares of the company’s stock, valued at approximately $62,566,139.07. The trade was a 0.97 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 3.32% of the company’s stock.

Chemed Price Performance

Shares of CHE stock opened at $598.17 on Friday. The business has a 50-day moving average of $580.24 and a 200 day moving average of $568.11. Chemed Co. has a 1-year low of $512.12 and a 1-year high of $632.53. The stock has a market capitalization of $8.76 billion, a PE ratio of 30.23, a P/E/G ratio of 2.15 and a beta of 0.43.

Chemed Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 14th. Shareholders of record on Monday, February 24th were given a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.33%. The ex-dividend date of this dividend was Monday, February 24th. Chemed’s payout ratio is 10.05%.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.